Publikationen in Zusammenarbeit mit Forschern von University of Colorado Cancer Center (6)

2022

  1. RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer

    Cancer, Vol. 128, Núm. 9, pp. 1801-1811

2018

  1. Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

    Journal of Thoracic Oncology, Vol. 13, Núm. 2, pp. 165-183

2017

  1. Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer

    Lung Cancer, Vol. 104, pp. 45-51

2016

  1. Clinicopathologic features of advanced squamous NSCLC

    Journal of Thoracic Oncology, Vol. 11, Núm. 9, pp. 1411-1422

  2. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment

    Journal of Thoracic Oncology, Vol. 11, Núm. 12, pp. 2066-2081

2015

  1. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): An open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 16, Núm. 7, pp. 763-774